Drugs / OMS201
last change Dec 2010 re-read 3 minutes ago

OMS201

Developed for
nephrolithiasis
Investigated by
Omeros Corporation

Trials 2

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00599664 Dec 2007 → Sep 2008 urolithiasis Omeros Corporation Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT00857090 Mar 2009 → Dec 2010 nephrolithiasis Omeros Corporation Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as OMS201 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00599664 ↗
1

NCT00857090 ↗

Route Other “OMS201 irrigation solution at 3X the base concentration during surgery” NCT00857090 ↗